InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,156.47
(
-0.05%
)
Post# of 252200
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 183
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Member Level

Re: None

Tuesday, 11/15/2022 7:53:31 PM

Tuesday, November 15, 2022 7:53:31 PM

Post# of 252200
This study is the first to use transcriptomics as a blood test to measure RNA levels in patients with long-term Lyme disease, and a study in search of a Co. I could actually invest in. Notable is suspected predatory practices by benefactor of this research center has probably made this research possible.

https://medicalxpress.com/news/2022-11-genes-potentially-long-term-lyme-disease.html?utm_source=nwletter&utm_medium=email&utm_campaign=daily-nwletter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up